Physician profile
Lance E Slade
NPI 1699858514
$1,193.90
in general payments reported to CMS, 2019-2025
24 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $65.93 · 2021: $83.20 · 2022: $35.58 · 2023: $290 · 2024: $356 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $847.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $212.94 | 2023-2024 | Azstarys |
| Glaxosmithkline, LLC. | $198.64 | 2019-2025 | Bexsero |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $124.46 | 2024 | Caplyta |
| Sanofi-Aventis U.S. LLC | $124.46 | 2025 | |
| Pfizer INC. | $108.94 | 2019-2024 | |
| Ironshore Pharmaceuticals INC. | $86.75 | 2020-2024 | |
| Cranial Technologies, INC | $76.35 | 2019-2025 | Doc Band |
| Astrazeneca Pharmaceuticals Lp | $48.74 | 2023-2024 | Flumist Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $39.99 | 2019-2021 | |
| Sobi, INC | $34.22 | 2019-2023 | |
| Sanofi Pasteur INC. | $29.24 | 2022-2023 | |
| Supernus Pharmaceuticals, INC. | $23.45 | 2023 | Qelbree |
| Novartis Pharmaceuticals Corporation | $22.99 | 2019 | |
| Seqirus USA INC | $19.18 | 2025 | Flucelvax |
| Tris Pharma INC | $18.30 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $16.27 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $8.98 | 2023 | Vaxelis, Vaxneuvance, Gardasil 9 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lance Slade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.